Genetic Test Now Available to Predict Radiation Therapy Side Effects in Prostate Cancer
PROSTOX ultra identifies patients at higher risk of developing late genitourinary toxicity from stereotactic body radiation therapy.
Read MorePosted by Edisource Vendor | Oct 2, 2025 | Prostate |
PROSTOX ultra identifies patients at higher risk of developing late genitourinary toxicity from stereotactic body radiation therapy.
Read MorePosted by Edisource Vendor | Oct 2, 2025 | Cardiovascular |
Study of more than 13,000 individuals demonstrates improved precision for emergency department triage and patient outcomes.
Read MorePosted by Edisource Vendor | Oct 1, 2025 | Sepsis |
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
Read MorePosted by Edisource Vendor | Oct 1, 2025 | Digital Pathology |
Tulsa Medical Lab chooses PathFlow system to unify diagnostic processes across multiple laboratory information systems.
Read MorePosted by Edisource Vendor | Sep 30, 2025 | Digital Pathology |
The collaboration will deploy FDA-cleared slide scanners across anatomic pathology services to support AI integration and address pathologist shortage.
Read More